BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8891480)

  • 1. Mediation of signal transduction in keratinocytes of human middle ear cholesteatoma by ras protein.
    Huang CC; Chen CT; Huang TS; Shinoda H
    Eur Arch Otorhinolaryngol; 1996; 253(7):385-9. PubMed ID: 8891480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The expression of Ras protein in human middle ear cholesteatoma].
    Xu Y; Jin K; Dong W
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1999 Apr; 34(2):74-6. PubMed ID: 12764851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expressions of c-jun and p53 proteins in human middle ear cholesteatoma: relationship to keratinocyte proliferation, differentiation, and programmed cell death.
    Shinoda H; Huang CC
    Laryngoscope; 1995 Nov; 105(11):1232-7. PubMed ID: 7475882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heat shock proteins in middle ear cholesteatoma.
    Shinoda H; Huang CC
    Otolaryngol Head Neck Surg; 1996 Jan; 114(1):77-83. PubMed ID: 8570255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles of cytokines and cell cycle regulating substances in proliferation of cholesteatoma epithelium.
    Tanaka Y; Kojima H; Miyazaki H; Koga T; Moriyama H
    Laryngoscope; 1999 Jul; 109(7 Pt 1):1102-7. PubMed ID: 10401849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alteration of epidermal differentiation in middle ear cholesteatoma.
    Stammberger M; Bujía J; Kastenbauer E
    Am J Otol; 1995 Jul; 16(4):527-31. PubMed ID: 8588655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The research progress of keratin's roles in the pathology of middle ear cholesteatoma].
    Feng YS; Si Y; Zhang ZG
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Nov; 54(11):870-874. PubMed ID: 31795552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Keratinocyte growth factor and receptor mRNA expression in cholesteatoma of the middle ear.
    Ishibashi T; Shinogami M; Kaga K; Fukaya T
    Acta Otolaryngol; 1997 Sep; 117(5):714-8. PubMed ID: 9349868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caspase-3, caspase-8, and nuclear factor-kappaB expression in human cholesteatoma.
    Miyao M; Shinoda H; Takahashi S
    Otol Neurotol; 2006 Jan; 27(1):8-13. PubMed ID: 16371840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of ErbB-2 protein in human middle ear cholesteatomas.
    Sakamoto T; Kondo K; Yamasoba T; Suzuki M; Sugasawa M; Kaga K
    Laryngoscope; 2004 Nov; 114(11):1988-91. PubMed ID: 15510028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical demonstration of c-myc oncogene product in middle ear cholesteatoma.
    Holly A; Sittinger M; Bujia J
    Eur Arch Otorhinolaryngol; 1995; 252(6):366-9. PubMed ID: 8679157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Id1 in acquired middle ear cholesteatoma.
    Zhang QA; Hamajima Y; Zhang Q; Lin J
    Arch Otolaryngol Head Neck Surg; 2008 Mar; 134(3):306-10. PubMed ID: 18347258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Terminal differentiation of epithelial cells in middle ear cholesteatoma: investigation of patterns of expression of protein kinase C-delta and protein kinase C-eta.
    Miyazaki H; Kojima H; Tanaka Y; Shiwa M; Koga T; Moriyama H
    Laryngoscope; 1999 Nov; 109(11):1785-92. PubMed ID: 10569408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The roles of interleukin-1 alpha, tumor necrosis factor-alpha and parathyroid hormone-related protein in bone resorption of cholesteatoma otitis].
    Kinoshita K
    Nihon Jibiinkoka Gakkai Kaiho; 1994 Aug; 97(8):1472-80. PubMed ID: 7931803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Keratinocyte growth factor receptor (KGF-R) in cholesteatoma tissue.
    Barbara M; Raffa S; Murè C; Manni V; Ronchetti F; Monini S; Torrisi MR
    Acta Otolaryngol; 2008 Apr; 128(4):360-4. PubMed ID: 18368565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Localization of intercellular adhesion molecule-1 in middle ear cholesteatoma.
    Shinoda H; Huang CC
    Eur Arch Otorhinolaryngol; 1995; 252(7):385-90. PubMed ID: 8562031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and localization of mRNA for epidermal growth factor and epidermal growth factor receptor in human cholesteatoma.
    Kojima H; Shiwa M; Kamide Y; Moriyama H
    Acta Otolaryngol; 1994 Jul; 114(4):423-9. PubMed ID: 7976315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the EGFR/Akt/NF-κB/cyclinD1 survival signaling pathway in human cholesteatoma epithelium.
    Liu W; Yin T; Ren J; Li L; Xiao Z; Chen X; Xie D
    Eur Arch Otorhinolaryngol; 2014 Feb; 271(2):265-73. PubMed ID: 23463347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Keratinocyte differentiation in acquired cholesteatoma and perforated tympanic membranes.
    Vennix PP; Kuijpers W; Peters TA; Tonnaer EL; Ramaekers FC
    Arch Otolaryngol Head Neck Surg; 1996 Aug; 122(8):825-32. PubMed ID: 8703383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of epidermal growth factor receptor in human middle ear cholesteatoma.
    Hsu YC; Ho KY; Chai CY; Lee KW; Wang LF; Wu SC; Kuo WR; Tsai SM
    Kaohsiung J Med Sci; 2003 Oct; 19(10):497-502. PubMed ID: 14620675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.